Myelodysplasia
Showing 26 - 50 of 307
Acute Myeloid Leukemia, Myelodysplasia Trial in United Kingdom (Oral azacitidine, Matched )
Recruiting
- Acute Myeloid Leukemia
- Myelodysplasia
- Oral azacitidine
- Matched placebo
-
Birmingham, United Kingdom
- +20 more
Oct 14, 2021
Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with
Recruiting
- Acute Leukemia
- +27 more
- HSCT with TBI Regimen
- HSCT with Non-TBI Regimen
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Apr 12, 2022
Previously Treated Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia With
Active, not recruiting
- Previously Treated Myelodysplastic Syndrome
- +7 more
- Decitabine
- Ipilimumab
-
Duarte, California
- +10 more
Jul 2, 2022
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia With Myelodysplasia-Related
Active, not recruiting
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +2 more
- Cytarabine
- +4 more
-
Tucson, Arizona
- +2 more
Aug 5, 2022
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Tumor, Acute Myeloid
Not yet recruiting
- Acute Myeloid Leukemia
- +3 more
- Azacitidine
- +6 more
- (no location specified)
Nov 15, 2022
Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia Trial in Lebanon (drug, radiation, procedure)
Recruiting
- Acute Myeloid Leukemia
- +8 more
- Cyclophosphamide
- +6 more
-
Lebanon, New HampshireDartmouth Hitchcock Medical Center, Norris Cotton Cancer Center
Apr 29, 2021
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Australia, Canada, United States
Completed
- Acute Myelogenous Leukemia
- +4 more
- Single Umbilical Cord Blood Unit Transplant
- +6 more
-
Birmingham, Alabama
- +37 more
Oct 13, 2021
Acute Leukemia, Myelodysplasia, Chronic Graft-versus-host-disease Trial in Australia, Canada (Cyclophosphamide, Anti-Thymocyte
Recruiting
- Acute Leukemia
- +2 more
- Cyclophosphamide
- Anti-Thymocyte globulin (rabbit)
-
Darlinghurst, New South Wales, Australia
- +8 more
Aug 30, 2021
Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial
Active, not recruiting
- Acute Leukemia
- +14 more
- Busulfan
- +10 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 18, 2022
Acute Myeloid Leukemia in Remission, Lymphoma in Remission, Non-progressive Myeloproliferative Syndrome Trial in Belgium,
Recruiting
- Acute Myeloid Leukemia in Remission
- +5 more
- Ex vivo capacities of CD4neg INkT expansion of the peripheral blood donor with the Predictor test
-
Antwerpen, Belgium
- +21 more
Sep 27, 2021
Biology of Long-Term Late Effects Following Hematopoietic Cell
Active, not recruiting
- Acute Lymphoblastic Leukemia/Lymphoma
- +4 more
-
Scottsdale, Arizona
- +31 more
Mar 8, 2022
A Post-Marketing Observational Study of VYXEOS™
Completed
- Acute Myeloid Leukemia With Myelodysplasia-Related Changes
- Therapy-Related Acute Myeloid Leukemia
-
Indianapolis, Indiana
- +6 more
Aug 4, 2020
Acute Leukemia, Myelodysplasia Trial in United States (Unmanipulated Bone Marrow Graft with Tacrolimus/Methotrexate, Mobilized
Completed
- Acute Leukemia
- Myelodysplasia
- Unmanipulated Bone Marrow Graft with Tacrolimus/Methotrexate
- +5 more
-
Duarte, California
- +27 more
Nov 22, 2021
MDS, Cardiovascular Diseases, Inflammation Trial in Toronto (Genetic Mutations, Inflammatory and lipid markers, Computed
Unknown status
- MDS
- +2 more
- Genetic Mutations
- +2 more
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Sep 30, 2019
Myelodysplastic Syndrome (MDS) Trial run by the NHLBI (ON 01910 Na)
Completed
- Myelodysplastic Syndrome (MDS)
- ON 01910 Na
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019
Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States
Completed
- Acute Myeloid Leukemia
- +19 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Lewes, Delaware
- +16 more
Aug 3, 2022
High-risk MDS With Excess Blasts Trial in Nancy, Vandoeuvre les Nancy (Myelogram)
Unknown status
- High-risk Myelodysplastic Syndromes With Excess Blasts
- Myelogram
-
Nancy, France
- +1 more
Aug 5, 2019
Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Indianapolis (Fludarabine + Total Marrow
Recruiting
- Acute Myeloid Leukemia
- +3 more
- Fludarabine + Total Marrow Irradiation
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
Jun 1, 2022
MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral
Not yet recruiting
- Myelodysplastic Syndromes
- +3 more
- Subcutaneous azacitidine
- Oral decitabine/cedazuridine
-
Newcastle, New South Wales, AustraliaCalvary Mater Newcastle
May 29, 2023
Aplastic Anemia Trial in Beijing (Avatrombopag+CsA)
Not yet recruiting
- Aplastic Anemia
-
Beijing, ChinaPeking union medical college hospital
Aug 16, 2023
Myelodysplastic Syndrome Trial in Japan (SyB C-1101 and Azacytidine)
Withdrawn
- Myelodysplastic Syndrome
- SyB C-1101 and Azacytidine
-
Nagoya, Aichi, Japan
- +3 more
Nov 14, 2022
Erythroid Response in Myelodysplasia Undergoing Chelation
Unknown status
- Myelodysplasia
- +2 more
-
Alessandria, AL, Italy
- +19 more
Jul 29, 2019
Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplasia Trial in United States (Mobilized Peripheral Blood Stem Cell
Active, not recruiting
- Acute Leukemia
- +3 more
- Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate
- +5 more
-
Birmingham, Alabama
- +38 more
Oct 25, 2021
Moxetumomab Pasudotox-tdfk (LUMOXITI)
Recruiting
- Hairy Cell Leukemia
-
Pueblo, Colorado
- +1 more
Aug 17, 2022